Internal Medicine, Pulmonary Disease · Boston, MA
NPI
1396721841
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
725 Albany St, Shapiro 9, Suite B
Boston, MA, 02118
Phone (617) 638-7480
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
985 services
Medicare patients, 2024
283
Average age 71
Drug cost, 2024
$12.4M
2,086 prescriptions
Company payments, 2025
$19K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harrison W Farber was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 291 times for 137 patients. In total Harrison W Farber billed 985 services in 26 codes, and Medicare paid $66K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 291 | 137 | $13.41 | $3,903 |
| 99214 Office E&M - Established | Facility | 270 | 137 | $73.86 | $20K |
| 99443 Telephone Services | Facility | 123 | 69 | $78.39 | $9,642 |
| 99291 Critical Care E&M | Facility | 75 | 45 | $173.26 | $13K |
| 93451 Percutaneous Transcatheterization | Facility | 72 | 66 | $101.49 | $7,307 |
| 99204 Office E&M - New | Facility | 44 | 44 | $101.87 | $4,482 |
| 99443 Telephone Services | Office | 22 | 15 | $102.03 | $2,245 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 11 | $13.77 | $262 |
| 99213 Office E&M - Established | Facility | 13 | 13 | $25.28 | $329 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $144.35 | $1,732 |
By year: 2022 $68K for 725 services; 2023 $69K for 730 services; 2024 $66K for 985 services.
Medicare prescription drug claims, 2024
In 2024, the drug Harrison W Farber prescribed most often to Medicare patients was Tadalafil, with 328 prescriptions and refills. In total Harrison W Farber wrote 2,086 Medicare prescriptions that cost $12.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tadalafil Generic | 328 | 338 | 51 | $178K |
| Ambrisentan Generic | 322 | 322 | 36 | $1.0M |
| Adempas Riociguat | 130 | 130 | 15 | $1.7M |
| Opsumit Macitentan | 128 | 128 | 17 | $1.6M |
| Furosemide Generic | 126 | 254 | 36 | $692 |
| Uptravi Selexipag | 115 | 115 | 17 | $2.7M |
| Sildenafil Citrate Generic | 73 | 87 | Under 11 | $11K |
| Tyvaso Dpi Treprostinil | 72 | 72 | Under 11 | $1.7M |
| Opsynvi Macitentan/Tadalafil | 68 | 68 | 13 | $873K |
| Winrevair Sotatercept-Csrk | 68 | 68 | Under 11 | $1.1M |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 58 | 80 | 12 | $50K |
| Torsemide Generic | 48 | 91 | 15 | $1,386 |
| Alyq Tadalafil | 47 | 51 | 16 | $29K |
| Orenitram Er Treprostinil Diolamine | 39 | 39 | Under 11 | $672K |
| Mycophenolate Mofetil Generic | 38 | 62 | Under 11 | $5,970 |
Brand drugs: 892 claims; generic drugs: 1,194 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harrison W Farber $19K ($19K in general payments such as food, travel and fees) from 21 companies. The largest payer was Merck Sharp & Dohme LLC with $7,726.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 11 | $7,726 |
| Actelion Pharmaceuticals US, Inc. JNJ | 8 | $4,261 |
| United Therapeutics Corporation UTHR | 12 | $3,669 |
| Alphatec Spine, Inc ATEC | 2 | $1,285 |
| Globus Medical, Inc. GMED | 6 | $837 |
| ZOLL Medical Corporation | 1 | $265 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $207 |
| Genzyme Corporation SNY | 2 | $198 |
| Medtronic, Inc. MDT | 4 | $180 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $146 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.